Display options
Share it on

Drug Alcohol Depend. 2021 Nov 01;228:109083. doi: 10.1016/j.drugalcdep.2021.109083. Epub 2021 Sep 21.

Drug and alcohol dependence acute effects of pod-style e-cigarettes in vaping-naïve smokers.

Drug and alcohol dependence

Natalia Peraza, Mariel S Bello, Sara J Schiff, Junhan Cho, Yi Zhang, Carly Callahan, Alayna Tackett, Adam M Leventhal

Affiliations

  1. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA.
  2. Department of Psychology, University of Southern California, Los Angeles, CA 90089, USA.
  3. Department of Preventive Medicine, Keck School of Medicine, University of Southern California, Los Angeles, CA 90033, USA; Department of Psychology, University of Southern California, Los Angeles, CA 90089, USA; Institute for Addiction Science, University of Southern California, Los Angeles, CA 90033, USA. Electronic address: [email protected].

PMID: 34600262 PMCID: PMC8631487 DOI: 10.1016/j.drugalcdep.2021.109083

Abstract

BACKGROUND: This study investigated the acute effects of exposure to pod-style e-cigarettes on subjective, behavioral, and physiological outcomes indicative of the potential to encourage vaping-naïve smokers to switch to e-cigarettes.

METHODS: In a within-subject experiment, never-vaping adult smokers interested in trying e-cigarettes (n = 24) completed 4 laboratory visits following 16-hr tobacco abstinence. Visits involved controlled puffing from preferred brand cigarettes (OwnCig) or a standardized pod-style e-cigarette with either no nicotine (NoNic), nicotine freebase (NicFreebase; 0.5% nicotine concentration), or nicotine salt (NicSalt E-Cig; 2.8% concentration) solutions. Outcomes included smoking urge, mood, user experience, plasma nicotine, and a behavioral task assessing ability to delay smoking.

RESULTS: NoNic, NicFreebase, and NicSalt pod-style e-cigarettes were significantly less effective than OwnCig at reducing smoking urge and increasing plasma nicotine, positive affect, satisfying user experience ratings, and ability to delay smoking on the behavioral task. Differences among pod-style e-cigarette conditions were limited to: (a) NicFreebase (vs. NoNic) preferentially suppressed participants' urge to smoke to alleviate negative mood, (b) NicFreebase (vs. NicSalt) slightly preferentially increased plasma nicotine; and (c) NicFreebase and NicSalt (vs. NoNic) produced higher aversive user experience ratings.

CONCLUSIONS: In tobacco deprived smokers' initial vaping experience, controlled administration of certain pod-style e-cigarettes with 0.5% NicFreebase or 2.8% NicSalt may be deficient comparators to cigarettes in terms of their capacity to acutely improve mood, deliver nicotine, suppress smoking motivation, and offer a satisfying user experience. Future research is needed to test pod-style e-cigarettes with higher nicotine doses and confirm whether NicFreebase vs. NicSalt enhances nicotine absorption.

Copyright © 2021 Elsevier B.V. All rights reserved.

Keywords: E-cigarette; Nicotine formulation; Smoking; Switching

References

  1. JAMA Netw Open. 2021 Jan 4;4(1):e2032757 - PubMed
  2. JAMA Netw Open. 2019 Nov 1;2(11):e1915494 - PubMed
  3. J Pers Soc Psychol. 1988 Jun;54(6):1063-70 - PubMed
  4. Psychopharmacology (Berl). 2021 Mar;238(3):825-831 - PubMed
  5. Biometrics. 1988 Dec;44(4):1049-60 - PubMed
  6. Intern Emerg Med. 2019 Sep;14(6):853-861 - PubMed
  7. Addiction. 2014 Nov;109(11):1801-10 - PubMed
  8. Addict Biol. 2009 Jan;14(1):99-107 - PubMed
  9. Pulm Pharmacol Ther. 2007;20(4):355-64 - PubMed
  10. J Appl Physiol (1985). 2020 Apr 1;128(4):1056-1058 - PubMed
  11. Harm Reduct J. 2018 Jun 28;15(1):33 - PubMed
  12. Expert Opin Drug Deliv. 2020 Dec;17(12):1727-1736 - PubMed
  13. Addiction. 2019 Oct;114(10):1842-1848 - PubMed
  14. Nicotine Tob Res. 2001 Feb;3(1):7-16 - PubMed
  15. Tob Control. 2016 Nov;25(Suppl 2):ii81-ii87 - PubMed
  16. J Abnorm Psychol. 2015 Aug;124(3):623-34 - PubMed
  17. Psychol Addict Behav. 2015 Mar;29(1):71-81 - PubMed
  18. Drug Alcohol Depend. 2016 Nov 01;168:176-180 - PubMed
  19. Addict Behav. 2007 May;32(5):912-23 - PubMed
  20. Biol Mass Spectrom. 1991 May;20(5):247-52 - PubMed
  21. Nicotine Tob Res. 2020 Jun 12;22(7):1239-1243 - PubMed
  22. Nicotine Tob Res. 2021 May 24;23(6):947-955 - PubMed
  23. Exp Clin Psychopharmacol. 2013 Aug;21(4):269-76 - PubMed
  24. Addiction. 2020 Dec;115(12):2197-2199 - PubMed
  25. Nicotine Tob Res. 2021 Oct 7;23(11):1821-1830 - PubMed
  26. Br J Addict. 1991 Sep;86(9):1119-27 - PubMed
  27. Drug Alcohol Depend. 2019 Oct 1;203:1-7 - PubMed
  28. Drug Alcohol Depend. 2020 Dec 1;217:108395 - PubMed
  29. Am J Health Behav. 2021 May 1;45(3):443-463 - PubMed
  30. JAMA Netw Open. 2020 Oct 1;3(10):e2020694 - PubMed
  31. Int J Environ Res Public Health. 2017 Jun 16;14(6): - PubMed
  32. Nicotine Tob Res. 2020 Apr 21;22(5):791-797 - PubMed
  33. Tob Control. 2020 Feb 10;: - PubMed
  34. Tob Control. 2020 Nov;29(6):679-686 - PubMed
  35. N Engl J Med. 2018 Sep 20;379(12):1099-1102 - PubMed
  36. J Chromatogr. 1981 Jan 2;222(1):61-70 - PubMed

Publication Types

Grant support